| Primary Site | Incidence | Mortality | ||||||
|---|---|---|---|---|---|---|---|---|
| 2004 | 2000 - 2004 | 2004 | 2000 - 2004 | |||||
| Count | Rate | Count | Rate | Count | Rate | Count | Rate | |
| All Sites | 11 | 360.2** | 69 | 496.7 | * | # | 32 | 230.6 |
| Esophagus | * | # | 2 | # | * | # | 1 | # |
| Stomach | * | # | 0 | # | * | # | 0 | # |
| Colon excluding Rectum | * | # | 5 | 34.4** | * | # | 3 | # |
| Rectum and Rectosigmoid Junction | * | # | 4 | # | * | # | 0 | # |
| Liver | * | # | 1 | # | * | # | 1 | # |
| Pancreas | * | # | 5 | 30.1** | * | # | 3 | # |
| Lung and Bronchus | * | # | 15 | 120.5** | * | # | 15 | 108.3** |
| Melanoma of the Skin | * | # | 2 | # | * | # | 0 | # |
| Prostate | * | # | 19 | 139.3** | * | # | 5 | 46.6** |
| Urinary Bladder | * | # | 3 | # | * | # | 0 | # |
| Kidney and Renal Pelvis | * | # | 5 | 36.6** | * | # | 0 | # |
| Brain and Other Nervous System | * | # | 0 | # | * | # | 0 | # |
| Non-Hodgkin Lymphoma | * | # | 0 | # | * | # | 0 | # |
| Myeloma | * | # | 0 | # | * | # | 0 | # |
| Leukemia | * | # | 1 | # | * | # | 1 | # |
| Primary Site | Incidence | Mortality | ||||||
|---|---|---|---|---|---|---|---|---|
| 2004 | 2000 - 2004 | 2004 | 2000 - 2004 | |||||
| Count | Rate | Count | Rate | Count | Rate | Count | Rate | |
| All Sites | 18 | 507.4** | 79 | 457.3 | 11 | 300.9** | 38 | 207.5 |
| Colon excluding Rectum | * | # | 10 | 56.4** | * | # | 2 | # |
| Rectum and Rectosigmoid Junction | * | # | 0 | # | * | # | 0 | # |
| Liver | * | # | 1 | # | * | # | 0 | # |
| Pancreas | * | # | 2 | # | * | # | 2 | # |
| Lung and Bronchus | 5 | 127.6** | 18 | 99.2** | * | # | 15 | 82.8** |
| Melanoma of the Skin | * | # | 4 | # | * | # | 0 | # |
| Breast | * | # | 13 | 78.2** | * | # | 3 | # |
| Cervix Uteri | * | # | 2 | # | * | # | 1 | # |
| Corpus Uteri | * | # | 4 | # | * | # | 0 | # |
| Ovary | * | # | 2 | # | * | # | 1 | # |
| Urinary Bladder | * | # | 2 | # | * | # | 1 | # |
| Kidney and Renal Pelvis | * | # | 4 | # | * | # | 3 | # |
| Brain and Other Nervous System | * | # | 0 | # | * | # | 1 | # |
| Non-Hodgkin Lymphoma | * | # | 2 | # | * | # | 1 | # |
| Myeloma | * | # | 0 | # | * | # | 0 | # |
| Leukemia | * | # | 3 | # | * | # | 2 | # |
Rates are per 100,000; Age-adjusted, 2000 US Std Population (Census P25-1130).
* Fewer than 5 cases, number suppressed to protect confidentiality.
** Rates based on fewer than 20 cases are unstable.
# Rate cannot be calculated.
Source: Indiana State Department of Health - Indiana State Cancer Registry and the Epidemiology Resource Center, Data Analysis Team, June 2007
Table of Contents
Table 5-57: Noble
Table 5-59: Orange
Table of Contents
Table 5-57: Noble
Table 5-59: Orange
